Skip to content
Search

Latest Stories

Centred Solutions partners with Paydens Pharmacy Group to provide FLOWRx Repeat Dispensing Hub technology

Centred Solutions, an automation and supply chain solution provider, has partnered with Paydens Pharmacy Group to provide them with the latest pharmacy hub and spoke solution.

The partnership will transform the way Paydens Group, an independent family-owned company, dispenses its repeat prescriptions.


The new system will not only allow pharmacy staff to focus on delivering services and improving patient care but also help in reducing errors.

Currently, repeat prescriptions are picked, labelled and sorted for dispensing manually by staff across all the branches, but once the new hub technology is installed, staff will no longer be required to spend hours administering and dispensing repeat prescriptions.

Pharmacies will receive labelled, sorted and bagged patient prescriptions straight from the hub ready to be collected by the patient in the spoke pharmacy.

Established in 1969, the group operates 113 pharmacies across the South-East of England.

The project will begin next month with the first 5 – 10 branches introducing the new system prior to a full roll out to the group.

Commenting on the partnership, Alexander Pay, managing director of Paydens said: “Paydens is committed to improving healthcare by seeking new ways of working and adapting to the future.  As an independent group we are able to respond quickly and make the right decisions for our teams and patients and we welcome the way that community pharmacy is evolving to become more focused on delivering services.

“Investing in new technology is key to making this happen and we believe that by taking this step it will enable our highly skilled, professional staff to provide an even better service to our communities”.

Paul O’Hanlon, managing director of Centred Solutions said: “We are thrilled to be forging this partnership with Paydens. It will be a true demonstration of how innovative technology can positively impact safety, drive efficiency and enable pharmacy professionals to spend more time on what matters most – face to face patient care.

“We look forward to beginning this journey with Paydens and inspiring other pharmacies across the UK and beyond to consider the value of our technology and what it can bring to a pharmacy business, whether that be a large pharmacy chain or single independent pharmacy looking for ways to improve their dispensing efficiency to release time for service delivery.”

The FlowRx product range, developed by the Centred Solutions, comprises three integrated solutions - FlowRx Connect, FlowRx Hub and FlowRx InStore. The system can work with most PMRs, WMS, robotic storage and dispensing systems, wholesalers or a combination of supply sources.

“Reducing the time they (pharmacists) spend on administrative tasks will enable them to focus on their patients and provide the very best services they can,” said John McConville, Paydens director of Pharmacy.

More For You

Walgreens Boots Alliance acquired by Sycamore in deal

Walgreens Boots Alliancehas entered into “a definitive agreement” to be acquired by Sycamore Partners

Gettyimages

Walgreens Boots Alliance acquired by Sycamore in £18.3 billion deal

Walgreens Boots Alliance(WBA) has entered into “a definitive agreement” to be acquired by Sycamore Partners, a private equity firm specializing in retail, consumer and distribution-related investments.

“The total value of the transaction represents up to $23.7 billion (£18.3 billion),” the company announced late last night (6).

Keep ReadingShow less
Professor Sir Stephen Powis at a press briefing

Professor Sir Stephen Powis, was appointed national medical director of NHS England in 2018

NHS

NHS England’s top doctor to step down following Amanda Pritchard’s resignation

Just a week after NHS England chief executive Amanda Pritchard announced her resignation, the organisation’s national medical director, Professor Sir Stephen Powis, has confirmed he will step down this summer after more than seven years in the role.

In a statement released on Thursday, Professor Powis revealed that he had informed Pritchard of his intention to leave in a letter back in January.

Keep ReadingShow less
PDA calls on GP practices to use funding boost to improve job security for pharmacists

Now, it is time to focus on the community pharmacy contract

gettyimages

PDA urges GP practices to ensure funding boost supports employed pharmacists

The Pharmacists' Defence Association (PDA) has called on GP practicesto ensure that all healthcare professionals they employ, including pharmacists, benefit from the 7.2% funding boost they received under a newly agreed contract.

GP employers are encouraged to improve “job security, pay and conditions” for employees with this increased funding.

Keep ReadingShow less
Fourth Shift: Investment in Innovative Medicines Crucial for NHS 10-Year Plan Success

Medicines should be viewed as an investment rather than a cost

gettyimages

ABPI wants to see a ‘fourth shift’ in NHS 10-Year Health Plan


The Association of the British Pharmaceutical Industry (ABPI) has called on the government to increase investment in innovative medicines and vaccines, describing it as a crucial “fourth shift” necessary to ensure the NHS is fit for the future.

Keep ReadingShow less
Lawrence Tallon named new MHRA chief executive

Lawrence Tallon

Photo credit: Sciana Network

Lawrence Tallon named new MHRA chief executive

Lawrence Tallon has been appointed as the new chief executive officer of the Medicines and Healthcare products Regulatory Agency (MHRA), effective 1 April 2025.

He will succeed Dame June Raine DBE, who is retiring after leading the agency since 2019.

Keep ReadingShow less